Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy-Reference-Cited by-同舟云学术

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

Published:2020-09-29 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Barrón Feliciano,Sánchez Roberto,Arroyo-Hernández Marisol,Blanco Carolina,Zatarain-Barrón Zyanya L.,Catalán Rodrigo,Ramos-Ramírez Maritza,Cardona Andrés F.,Flores-Estrada Diana,Arrieta Oscar

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference24 articles.

1. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review.;Friedman;JAMA Oncol.,2016

3. Longitudinal evaluation of lung function in patients with advanced non-small cell lung cancer treated with concurrent chemoradiation therapy.;Torre-Bouscoulet;Int J Radiat Oncol Biol Phys.,2018

4. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.;Arrieta;J Thorac Oncol.,2009

5. Safety and tolerability of PD-1/PD-L1 inhibitors compared with chemotherapy in patients with advanced cancer: a meta-analysis.;Nishijima;Oncologist.,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis;The Oncologist;2024-06-17

2. Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management;Frontiers in Immunology;2024-02-15

3. Development and validation of a nomogram for predicting immune‐related pneumonitis after sintilimab treatment;Cancer Medicine;2024-01-12

4. Therapeutic efficacy of rare earth carbonate with chemoradiotherapy in late-stage non-small cell lung cancer: a cohort prospective study;Frontiers in Endocrinology;2023-12-15

5. Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study;Current Oncology;2023-12-09